The uphill battle facing antiobesity drugs

International Journal of Obesity

Volumn 39, Issue 3, 2015, Pages 377-378

  Daubresse, M ^a,b   Alexander, G C ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE DERIVATIVE; ANTIOBESITY AGENT; PHENTERMINE; TOPIRAMATE;

BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; HUMAN; NOTE; OBESITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VALVULAR HEART DISEASE; WEIGHT REDUCTION; CLINICAL PRACTICE; DRUG EFFECTS; FOOD AND DRUG ADMINISTRATION; HEALTH SURVEY; UNITED STATES;

ANTI-OBESITY AGENTS; HUMANS; OBESITY; POPULATION SURVEILLANCE; PRACTICE PATTERNS, PHYSICIANS'; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WEIGHT LOSS;

EID: 84924739078     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2014.169     Document Type: Note

References (12)

1. IOM (Institute of Medicine). Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation. The National Academies Press: Washington, DC, USA, 2012
2. Dietz WH, Benken DE, Hunter AS. Public health law and the prevention and control of obesity. Milbank Q. 2009; 87: 215-227
3. Haslam D. Sibutramine: gone, but not forgotten. Pract Diab Int 2010; 27: 96-97
4. Topol EJ, Bousser M-G, Fox KAA, Montelescot G. Termination of the CRESCENDO trial-Authors" reply. Lancet 2010; 376: 1984-1985
5. Staton T. "With Qsymia still flailing, Vivus to cut 20 jobs, replace CFO'. Available at http://www.fiercepharma.com/story/qsymia-still-flailing-vivus-cut-20-jobs-replace-cfo/2013-11-06?utm-medium=nl-source=internal (accessed 14 January 2014
6. Bray GA. Use and abuse of appetite-suppressant drugs in the treatment of obesity. Ann Intern Med. 1993; 119: 707-713
7. Jensen MD, Ryan DH. New obesity guidelines: promise and potential. JAMA 2014; 311: 23-24
8. Ware JH. Interpreting incomplete data in studies of diet and weight loss. N Engl J Med. 2003; 348: 2136-2137
9. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial-A prospective controlled intervention study of bariatric surgery. J Intern Med. 2013; 273: 219-234
10. ClinicalTrials.gov (metreleptin pramlintide). Available at www.clinicaltrials. gov/ct2/results?term=metreleptin+pramlintideSearch-rfdoi=Search.clinic (accessed 14 January 2014
11. Blomain ES, Dirhan DA, Valentino MA, Kim GW, Waldman SA. Mechanisms of weight regain following weight loss. ISRN Obes 2013; 16: 210524
12. Ochner CN, Barrios DM, Lee CD, Pi-Sunyer FX. Biological mechanisms that promote weight regain following weight loss in obese humans. Physiol Behav 2013; 120: 106-113